Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea
2
조회
0
다운로드
12
인용
0
참고문헌
키워드
초록
Background: As the coronavirus disease 2019 (COVID-19) pandemic has progressed, there has been a growing awareness of the long-term impacts of the COVID-19 infection. However, until recently, there was no published study that investigated COVID-19-related sequelae and related factors for greater than six months from the onset of COVID-19 symptoms or the time of COVID-19 diagnosis in Korea. Materials and Methods: Online survey and statistical analysis were conducted by Kyungpook National University Hospital on 5,252 patients diagnosed as COVID-19 between February 18, 2020 and March 14, 2020. Responders aged between 16 and 70 years were included. Longterm sequelae were defined as persistent symptoms or signs ≥ 6 months after acute COVID-19 infection. The survey was conducted from September 8, 2020 to September 10, 2020. Clinical characteristics and self-reported clinical sequelae of the responders were analyzed to investigate the prevalence and factors associated with sequelae using descriptive and multivariate logistic regression analysis. Results: The median period from the date of the first symptom onset or COVID-19 diagnosis to the time of the survey was 195 (interquartile range [IQR] 191 - 200) days. The response rate was 17.1% (900 out of 5,252). The median age was 31 (IQR 24.0 - 47.0) years old, and 627 responders were female (69.7%). Regarding the disease severity, 29 (3.2%) were asymptomatic, 763 (84.8%) mild, 86 (9.6%) moderate, 17 (1.9%) severe, and 5 (0.6%) critical. In total, 591 (65.7%) responders suffered from COVID-19-related long-term sequelae and 78 (8.6%) responders were receiving outpatient treatment for COVID-19-related long-term sequelae. The most common symptoms identified during the isolation period were anosmia and ageusia at 44.5% and 43.5%, respectively. Fatigue was the most common long-term sequelae, accounting for 253 (26.2%) responders, followed by concentration difficulty, amnesia, cognitive dysfunction, anxiety, and depression, which accounted for over 20%. Female gender was identified as the factor associated with mental and psychological long-term sequelae (P <0.05). Conclusion: The results showed that the rate of COVID-19-related long-term sequelae was 65.7%. The most common long-term sequela was fatigue. The risk factor identified was female gender. It was found that the long-term sequelae had various manifestations, including mental and psychological aspects. To improve the care of COVID-19 recovered patients with COVID-19-related long-term sequelae, the participation of a comprehensive and an interdisciplinary group of researchers is required.
Abstract
Background: As the coronavirus disease 2019 (COVID-19) pandemic has progressed, there has been a growing awareness of the long-term impacts of the COVID-19 infection. However, until recently, there was no published study that investigated COVID-19-related sequelae and related factors for greater than six months from the onset of COVID-19 symptoms or the time of COVID-19 diagnosis in Korea. Materials and Methods: Online survey and statistical analysis were conducted by Kyungpook National University Hospital on 5,252 patients diagnosed as COVID-19 between February 18, 2020 and March 14, 2020. Responders aged between 16 and 70 years were included. Longterm sequelae were defined as persistent symptoms or signs ≥ 6 months after acute COVID-19 infection. The survey was conducted from September 8, 2020 to September 10, 2020. Clinical characteristics and self-reported clinical sequelae of the responders were analyzed to investigate the prevalence and factors associated with sequelae using descriptive and multivariate logistic regression analysis. Results: The median period from the date of the first symptom onset or COVID-19 diagnosis to the time of the survey was 195 (interquartile range [IQR] 191 - 200) days. The response rate was 17.1% (900 out of 5,252). The median age was 31 (IQR 24.0 - 47.0) years old, and 627 responders were female (69.7%). Regarding the disease severity, 29 (3.2%) were asymptomatic, 763 (84.8%) mild, 86 (9.6%) moderate, 17 (1.9%) severe, and 5 (0.6%) critical. In total, 591 (65.7%) responders suffered from COVID-19-related long-term sequelae and 78 (8.6%) responders were receiving outpatient treatment for COVID-19-related long-term sequelae. The most common symptoms identified during the isolation period were anosmia and ageusia at 44.5% and 43.5%, respectively. Fatigue was the most common long-term sequelae, accounting for 253 (26.2%) responders, followed by concentration difficulty, amnesia, cognitive dysfunction, anxiety, and depression, which accounted for over 20%. Female gender was identified as the factor associated with mental and psychological long-term sequelae (P <0.05). Conclusion: The results showed that the rate of COVID-19-related long-term sequelae was 65.7%. The most common long-term sequela was fatigue. The risk factor identified was female gender. It was found that the long-term sequelae had various manifestations, including mental and psychological aspects. To improve the care of COVID-19 recovered patients with COVID-19-related long-term sequelae, the participation of a comprehensive and an interdisciplinary group of researchers is required.
참고문헌 (31)
- Guan WJ, "Clinical characteristics of coronavirus disease 2019 in China", N Engl J Med, 382, pp.1708~1720 (2020)
- Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study", Lancet, 395, pp.507~513 (2020)
- Lee JY, "Epidemiological and clinical characteristics of coronavirus disease 2019 in Daegu, South Korea", Int J Infect Dis, 98, pp.462~466 (2020)
- Logue JK, "Sequelae in adults at 6 months after COVID-19 infection", JAMA Netw Open, 4, pp.e210830~ (2021)
- Peluso MJ, "Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection", COVID-19, 2021, ~
- Lam MH, "Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up", Arch Intern Med, 169, pp.2142~2147 (2009)
- Sheng B, "The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases", Eur Psychiatry, 20, pp.236~242 (2005)
- Rogers JP, "Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic", Lancet Psychiatry, 7, pp.611~627 (2020)
- Postolache TT, "Targetable biological mechanisms implicated in emergent psychiatric conditions associated sith SARS-CoV-2 infection", JAMA Psychiatry (2020)
- So Hee Lee, "Depression as a Mediator of Chronic Fatigue and Post-Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors", PSYCHIATRY INVESTIGATION, 16(1), pp.59~64 (2019), 대한신경정신의학회[DOI]
- Nalbandian A, "Post-acute COVID-19 syndrome", Nat Med, 27, pp.601~615 (2021)
- Xiong Q, "Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study", lin Microbiol Infect, 27, pp.89~95 (2021)
- Sethuraman N, "Interpreting diagnostic tests for SARS-CoV-2", JAMA, 323, pp.2249~2251 (2020)
- Cicco Sebastiano, "Long-Term Follow-Up May be Useful in Coronavirus Disease 2019 Survivors to Prevent Chronic Complications", Infection and Chemotherapy, 52(3), pp.407~409 (2020), 대한감염학회[DOI]
- Carfì A, "Persistent symptoms in patients after acute COVID-19", JAMA, 324, pp.603~605 (2020)
- Huang C, "6-month consequences of COVID-19 in patients discharged from hospital: a cohort study", Lancet, 397, pp.220~232 (2021)
- Chua SE, "Stress and psychological impact on SARS patients during the outbreak", Can J Psychiatry, 49, pp.385~390 (2004)
- Hyun-Chung Kim, "Psychiatric Findings in Suspected and Confirmed Middle East Respiratory Syndrome Patients Quarantined in Hospital: A Retrospective Chart Analysis", PSYCHIATRY INVESTIGATION, 15(4), pp.355~360 (2018), 대한신경정신의학회
- Hopkins RO, "Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome", Am J Respir Crit Care Med, 160, pp.50~56 (1999)
- Troyer EA, "Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms", Brain Behav Immun, 87, pp.34~39 (2020)
- Mohammadi S, "Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms", Mol Neurobiol, 57, pp.5263~5275 (2020)
- Russell A, "Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome", Psychoneuroendocrinology, 100, pp.276~285 (2019)
- Wohleb ES, "Integrating neuroimmune systems in the neurobiology of depression", Nat Rev Neurosci, 17, pp.497~511 (2016)
- Helms J, "Meziani F. Neurologic features in severe SARS-CoV-2 infection", N Engl J Med, 382, pp.2268~2270 (2020)
- Kutlu Ö, "Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic", J Dermatolog Treat, 1 (2020)
- Rodríguez-Jiménez P, "Alopecia areata not due by isotretinoin. A thought in COVID-19 time", Dermatol Ther, 33, pp.e13451~ (2020)
- FIvenson D, "COVID-19: association with rapidly progressive forms of alopecia areata", Int J Dermatol, 60, pp.127~ (2021)
- Qi R, "Psychological morbidities and fatigue in patients with confirmed COVID-19during disease outbreak: prevalence and associated biopsychosocial risk factors" (2020)
- 강승지, "Age-Related Morbidity and Mortality among Patients with COVID-19", Infection and Chemotherapy, 52(2), pp.154~164 (2020), 대한감염학회[DOI]
- Del Rio C, "Long-term health consequences of COVID-19", JAMA, 324, pp.1723~1724 (2020)
- Goërtz YMJ, "Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?", ERJ Open Res, 6, pp.00542~02020 (2020)